SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040132
Filing Date
2023-11-09
Accepted
2023-11-09 17:23:59
Documents
92
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1078887
2 ex31-1.htm EX-31.1 7449
3 ex31-2.htm EX-31.2 7447
4 ex32-1.htm EX-32.1 5001
5 ex32-2.htm EX-32.2 4999
  Complete submission text file 0001493152-23-040132.txt   6079012

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfri-20230930.xsd EX-101.SCH 57950
7 XBRL CALCULATION FILE bfri-20230930_cal.xml EX-101.CAL 79676
8 XBRL DEFINITION FILE bfri-20230930_def.xml EX-101.DEF 245541
9 XBRL LABEL FILE bfri-20230930_lab.xml EX-101.LAB 416351
10 XBRL PRESENTATION FILE bfri-20230930_pre.xml EX-101.PRE 350724
86 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 813597
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 231393869
SIC: 2834 Pharmaceutical Preparations